Skip to content

An Ayurvedic Perspective on Infertility: The Role of Panchakarma Therapies

Role of Panchakarma in Ayurvedic Management of Infertility An Observational Clinical Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/102017
Enrollment
40
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

J S AYURVED MAHAVIDYALAYA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Couples not receiving any hormonal treatment or ART. Female age: 21 to 35 years; Male age: 21 to 40 years. Patients indicated for Panchakarma.

Exclusion criteria

Exclusion criteria: Female partner with: Ovarian Failure / Premature Ovarian Insufficiency Male partner with: Azoospermia Diagnosed with varicocele Grade III or Testicular atrophy. Both Partners: Associated with any other systemic co-morbidities. Congenital/Structural abnormalities related to reproductive organs. Contra indicated for Panchakarma.

Design outcomes

Primary

MeasureTime frame
Confirmation of clinical pregnancy, assessed by a positive Urine Pregnancy Test (UPT) and/or Transvaginal Ultrasound (TVS).Timepoint: Participants will be followed up every 4th week. Confirmation of clinical pregnancy will be carried out at follow-up visits only in cases of missed menses or suspected pregnancy, and not routinely in all participants.

Secondary

MeasureTime frame
1. Menstrual Parameters: Regularity of Cycle Duration of Bleeding Quantity of Bleeding Pain During Menses Cycle Interval 2. Hormonal Profile (if applicable) FSH, LH, TSH, Prolactin, AMH 3. Ovulatory function (if applicable) Ovulation Follicular Maturity Follicular Rupture Endometrial Thickness 4. Semen Analysis (male partner, where applicable) Sperm Count (millions/mL) Motility (%) Morphology (%) Timepoint: 1. Menstrual parameters: Assessed at baseline & during each menstrual cycle throughout the study by history & clinical examination. 2. Hormonal profile: Assessed at baseline & during follow-up only when clinically indicated. 3. Ovulatory function (where applicable): Assessed during the peri-ovulatory period of selected cycles by ultrasonography, as clinically indicated. 4. Semen analysis (male partner, where applicable): Assessed at baseline & during follow-up only if clinically indicated.

Countries

India

Contacts

Public ContactProf Dr Kalapi B Patel

J S Ayurveda College

drkalapi@rediffmail.com9428661664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026